MedPath
NMPA Approval

Satralizumab Injection

国药准字SJ20210017

April 30, 2021

Drug Information

萨特利珠单抗注射液

安适平

注射剂

120mg(1ml)/支

生物制品

April 30, 2021

April 29, 2026

Company Information

Applicant Company

Grenzacherstrasse 124, CH-4070 Basel, Switzerland

Manufacturing Company

utsunomiya plant of chugai pharma manufacturing co., ltd.

16-3, Kiyohara Kogyodanchi, Utsunomiya, Tochigi, Japan

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

萨特利珠单抗注射液 - NMPA 批准文号 | MedPath